title: Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
authors.affiliation: Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragonet.es
authors.forename: Vincent
authors.initials: V
authors.lastname: Soriano
authors.forename: Marina
authors.initials: M
authors.lastname: Núñez
authors.forename: Nuria
authors.initials: N
authors.lastname: Camino
authors.forename: Ivana
authors.initials: I
authors.lastname: Maida
authors.forename: Pablo
authors.initials: P
authors.lastname: Barreiro
authors.forename: Miriam
authors.initials: M
authors.lastname: Romero
authors.forename: Luz
authors.initials: L
authors.lastname: Martin-Carbonero
authors.forename: Javier
authors.initials: J
authors.lastname: Garcia-Samaniego
authors.forename: Juan
authors.initials: J
authors.lastname: González-Lahoz
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D011237:Predictive Value of Tests; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012367:RNA, Viral; D012254:Ribavirin